Figure 5. Somatic mutation analysis and clinicopathological characteristics based on riskscore in TCGA cohort. (A) Analysis of somatic mutation in risk groups. (B) Distribution of TMB in risk groups. (C) K-M curve combining risk grouping with TMB. (D) The distribution of riskscore among different clinicopathological characteristics in the TCGA queue.